Who
Nir Naor
EVP, CFO & Treasurer
Company insider
Files Form 4 as: EVP, CFO & Treasurer, Neuronetics; Director, Brainstorm Cell Therapeutics; CFO, Axogen.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 19 Jun 2023
- Last trade
- 23 Jul 2026
- Last filed
- 23 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jul 2026filed 23 Jul 2026 | STIM NeuroneticsMedical Devices | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 23 Jul 2026filed 23 Jul 2026 | STIM NeuroneticsMedical Devices | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 26 Feb 2026filed 20 May 2026 | Brainstorm Cell Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $126K180,000 at $0.70 | filing |
| 26 Feb 2026filed 20 May 2026 | Brainstorm Cell Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $126K180,000 at $0.70 | filing |
| 6 Jan 2025filed 6 Jan 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $596K39,132 at $15.22 | filing |
| 1 Jan 2025filed 3 Jan 2025 | Brainstorm Cell TherapeuticsBiotechnology | SEC FORM 4 Code A | —30,666 at $0.00 | filing |
| 1 Jan 2024filed 4 Jan 2024 | AXGN AxogenMedical Devices | SEC FORM 4 Code A | —300,000 | filing |
| 19 Jun 2023filed 21 Jun 2023 | Brainstorm Cell TherapeuticsBiotechnology | SEC FORM 4 Code A | —11,999 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.